Zynex Inc logo

ZYXI - Zynex Inc Share Price

$13.87 0.4  2.9%

Last Trade - 14/05/21

Small Cap
Market Cap £334.3m
Enterprise Value £310.9m
Revenue £63.4m
Position in Universe 3572nd / 6851
Unlock ZYXI Revenue
Relative Strength (%)
1m -8.95%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -54.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
11.6 13.3 23.4 31.9 45.5 80.1 139.6 201.9 +47.1%
+9,939 +26.5 -0.4 -6.4 +41.4 +114.9
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, Zynex Inc.revenues increased 58% to $24.1M. Net loss totaled $706Kvs. income of $2.9M. Revenues reflect Public UtilitiesInventory Supplies increase of 51% to $17.8M, Devicesincrease of 85% to $6.4M. Net loss reflects Sales andMarketing - Balancing value increase from $5.2M to $13.8M(expense), General and administrative - Balancing increaseof 46% to $4.8M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ZYXI
Graphical History


ZYXI Revenue Unlock ZYXI Revenue

Net Income

ZYXI Net Income Unlock ZYXI Revenue

Normalised EPS

ZYXI Normalised EPS Unlock ZYXI Revenue

PE Ratio Range

ZYXI PE Ratio Range Unlock ZYXI Revenue

Dividend Yield Range

ZYXI Dividend Yield Range Unlock ZYXI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ZYXI EPS Forecasts Unlock ZYXI Revenue
Profile Summary

Zynex, Inc. manufactures and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The Company operates through medical devices segment, which include electrotherapy and pain management products. The Company conducts its business through its subsidiaries and the operating subsidiary is Zynex Medical, Inc. (ZMI). The Company’s devices are intended for pain management to reduce reliance on drugs and provide rehabilitation and mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS). The Company's devices are small, portable, battery-operated and include an electrical pulse generator that is connected to the body via electrodes.

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated December 31, 2001
Public Since February 29, 2012
No. of Shareholders: 246
No. of Employees: 768
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Capital Market
Shares in Issue 34,846,656
Free Float (0.0%)
Eligible for
ZYXI Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ZYXI
Upcoming Events for ZYXI
Monday 26th July, 2021 Estimate
Q2 2021 Zynex Inc Earnings Release
Monday 25th October, 2021 Estimate
Q3 2021 Zynex Inc Earnings Release
Frequently Asked Questions for Zynex Inc
What is the Zynex Inc share price?

As of 14/05/21, shares in Zynex Inc are trading at $13.87, giving the company a market capitalisation of £334.3m. This share price information is delayed by 15 minutes.

How has the Zynex Inc share price performed this year?

Shares in Zynex Inc are currently trading at $13.87 and the price has moved by -26.82% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zynex Inc price has moved by -48.62% over the past year.

What are the analyst and broker recommendations for Zynex Inc?

Of the analysts with advisory recommendations for Zynex Inc, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Zynex Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Zynex Inc next release its financial results?

Zynex Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Zynex Inc dividend yield?

Zynex Inc does not currently pay a dividend.

Does Zynex Inc pay a dividend?

Zynex Inc does not currently pay a dividend.

When does Zynex Inc next pay dividends?

Zynex Inc does not currently pay a dividend.

How do I buy Zynex Inc shares?

To buy shares in Zynex Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zynex Inc?

Shares in Zynex Inc are currently trading at $13.87, giving the company a market capitalisation of £334.3m.

Where are Zynex Inc shares listed? Where are Zynex Inc shares listed?

Here are the trading details for Zynex Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: ZYXI
What kind of share is Zynex Inc?

Based on an overall assessment of its quality, value and momentum, Zynex Inc is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zynex Inc share price forecast 2021?

Shares in Zynex Inc are currently priced at $13.87. At that level they are trading at 98.07% discount to the analyst consensus target price of 0.00.

Analysts covering Zynex Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.37 for the next financial year.

How can I tell whether the Zynex Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zynex Inc. Over the past six months, the relative strength of its shares against the market has been -12.17%. At the current price of $13.87, shares in Zynex Inc are trading at -14.05% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zynex Inc PE Ratio?

The Zynex Inc PE ratio based on its reported earnings over the past 12 months is 85.99. The shares are currently trading at $13.87.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Zynex Inc?

Zynex Inc's management team is headed by:

Thomas Sandgaard - CHM
Daniel Moorhead - CFO
Barry Michaels - IND
Michael Cress - IND
Joshua Disbrow - IND
Anna Lucsok - COO
Donald Gregg - VPR
Who are the major shareholders of Zynex Inc?

Here are the top five shareholders of Zynex Inc based on the size of their shareholding:

Sandgaard (Thomas) Individual Investor
Percentage owned: 43.31% (15.1m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 8.33% (2.90m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 3.75% (1.31m shares)
Hood River Capital Management LLC Investment Advisor
Percentage owned: 3.27% (1.14m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 3.18% (1.11m shares)
Similar to ZYXI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.